Tetris Therapeutics, a Singapore-based biotech startup that develops antibody-drug conjugates (ADCs) for cancer therapy, has raised $15 million in seed funding from Trinity Innovation Bioventure Singapore (TIBS).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
